Appraisal of the MTT-based Assay as a Useful Tool for Predicting Drug Chemosensitivity in Leukemia
- 1 January 2003
- journal article
- review article
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 44 (11), 1957-1962
- https://doi.org/10.1080/1042819031000116607
Abstract
The MTT-based assay relies upon the cellular reduction of tetrazolium salts to their intensely colored formazans. The test is easy to perform in hematological malignancies and is adaptable for high throughput of samples, although there are some minor limitations in its application resulting from metabolic interference. This class of assays are highly accurate for predicting drug resistance, whereas their predictive value for drug sensitivity depends on the type of disease and drug or drug combination used. They have been found to predict clinical response to fludarabine FLD in B-CLL and were useful for predetermining clinical potential of a single drug or drug combination in AML patients. Extensive studies with ALL patients have supported their advantage for selecting effective drug treatment of the disease. To conclude, pretreatment chemosensitivity assays may help in the selection of chemotherapeutic drugs with the greatest likelihood for clinical effectiveness, and in the exclusion of uneffective therapy. This can lead to improved disease management, response, survival and use of financial resources.Keywords
This publication has 39 references indexed in Scilit:
- An improved MTT assay using the electron-coupling agent menadioneJournal of Immunological Methods, 1994
- An improved MIT assayJournal of Immunological Methods, 1993
- In vitro chemosensitivity testing in chronic lymphocytic leukaemia patientsLeukemia Research, 1991
- Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assayJournal of Immunological Methods, 1991
- Towards an optimized MTT assayJournal of Immunological Methods, 1990
- Anin vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemiaCancer, 1990
- Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemiaBritish Journal of Cancer, 1989
- The synthesis of XTT: A new tetrazolium reagent that is bioreducible to a water‐soluble formazanJournal of Heterocyclic Chemistry, 1988
- An improved colorimetric assay for interleukin 2Journal of Immunological Methods, 1986
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983